logo
Shun 'sterlisied living', reconnect with nature to tackle Covid-like pandemics: Renowned scientist

Shun 'sterlisied living', reconnect with nature to tackle Covid-like pandemics: Renowned scientist

Time of India4 days ago
Shunning today's "sterilised" and "hyper-clean" lifestyle and reconnecting with natural elements like soil, rivers, fresh air can strengthen people's
immune system
and better prepare them to face
Covid-like pandemics
in future, renowned scientist
Ajai Kumar Sonkar
has said.
In an exclusive conversation with PTI, Sonkar, whose development of pearl-making techniques through state-of-the-art
tissue culture
surprised the world, used an analogy comparing the human body to a mobile phone.
Explore courses from Top Institutes in
Select a Course Category
"By coming in touch with nature, the human body gets information about bacteria and their evolving forms just like a mobile phone needs regular software updates to function properly," he said.
"Like
Covid
, any future pandemic will not occur merely due to bacteria and viruses, but because of our own biological mistakes. To deal with such a nightmare, we must
reconnect with nature
," said Sonkar, who was awarded
Padma Shri
, India's fourth-highest civilian award, in 2022.
Sonkar, who has conducted in-depth research for years on microbiology and aquatic biology in India and abroad, said, "Modern humans have become so sterilised (artificial and chemical cleanliness shields) that now their bodily immune system is unable to even recognise environmental pathogens."
Live Events
"As long as humans were in contact with soil, rivers, and natural air, their immune system continuously received information about bacteria and their evolving forms (microbial updates), just like how mobile phones receive regular software updates," he added.
Sonkar said today's "hyper-clean" culture has distanced the people from this natural protective shield. "We have not only sterilised our homes but have also separated our bodies from the microbes that protect us from diseases," he said.
Revealing a particularly startling finding from his research, he said the
Ganga River
is a living microbial network that reads the microbial data of anyone entering it and responds with protective
bacteriophages
-- viruses that destroy harmful bacteria.
"When people bathe in the river, they introduce their body's microbes to the Ganges, and in return, the Ganges protects them by destroying pathogens through bacteriophages," he said.
"This gives natural training to the human body's immune system. This is the reason why people who come in contact with it are more resistant to new diseases," Sonkar, who is considered among the world's leading scientists on microbiome and bacteriophages of the Ganga, said.
Sonkar, who has spent decades researching microbiology and aquatic ecosystems in India and abroad, claimed that developed nations like the US and those in Europe were severely affected by Covid due to "microbial amnesia."
"Societies like Europe and America have been victims of 'microbial amnesia' for decades. People there live in such clean and sterilised environments that no new 'data' reaches their immune systems.
"They are cut off from the changing forms of bacteria/viruses. As a result, whenever a new bacterium arrives, the body takes time to recognise it and the death rate increases," he said.
When asked about the way forward, Sonkar said, "We must reconnect with nature. We must see the Ganga not just as a sacred river but as a teacher... Reactivating the biological systems of soil, rivers, and air could be the real strategy to prevent pandemics.
"Vaccination is only an insufficient response. In a constantly changing climate environment, vaccination can never replace
natural microbial intelligence
. Living with the natural ability to fight bacteria and their new forms is the real prevention of any pandemic," he added.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Zydus Lifesciences gets tentative nod from USFDA for generic blood cancer drug
Zydus Lifesciences gets tentative nod from USFDA for generic blood cancer drug

News18

timean hour ago

  • News18

Zydus Lifesciences gets tentative nod from USFDA for generic blood cancer drug

New Delhi, Jul 24 (PTI) Zydus Lifesciences Ltd on Thursday said it has received tentative approval from the US health regulatory agency for its generic version of cancer treatment drug Ibrutinib tablets. The tentative approval granted by the US Food and Drug Administration (USFDA) is for Ibrutinib tablets of strengths 140 mg, 280 mg, and 420 mg, Zydus Lifesciences said in a statement. The Ibrutinib tablets will be produced at Zydus Lifesciences Ltd SEZ, Ahmedabad, it added. The company said Ibrutinib is indicated for the treatment of adult patients with different types of blood cancers, Chronic lymphocytic leukaemia (CLL)/Small lymphocytic lymphoma (SLL), and Waldenstrom's macroglobulinemia (WM). Citing IQVIA MAT May 2025, Zydus said Ibrutinib tablets had annual sales of USD 2148.9 million in the US. PTI RKL DR DR Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

Lupin gets USFDA nod for generic diabetes drugs
Lupin gets USFDA nod for generic diabetes drugs

News18

timean hour ago

  • News18

Lupin gets USFDA nod for generic diabetes drugs

Agency: PTI New Delhi, Jul 24 (PTI) Drug maker Lupin on Thursday said it has received approval from the US health regulator to market generic medications to treat diabetes. The company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug applications for Liraglutide Injection single-patient-use prefilled pens and glucagon for injection vials, the drug maker said in a statement. Both the products will be manufactured at the company's injectable facility in Nagpur, it added. Liraglutide Injection, 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pen is bioequivalent to Novo Nordisk Inc's Victoza Injection. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older, with type 2 diabetes mellitus. As per IQVIA MAT May 2025 data, the injection had an estimated annual sale of USD 458 million in the US. Glucagon for Injection USP, 1 mg/vial, packaged in an emergency kit1, is bioequivalent to Eli Lilly and Company's Glucagon for Injection, 1 mg/vial. It is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus. Glucagon for Injection USP, 1 mg/vial, had an estimated annual sale of USD 124 million in the US. 'This is a meaningful enhancement to our portfolio and reaffirms our commitment to expanding access to critical therapies for our patients," Shahin Fesharaki, Chief Scientific Officer, Lupin said. Lupin shares were trading 0.94 per cent up at Rs 1,938.50 apiece on BSE. PTI MSS MSS ANU ANU view comments First Published: July 24, 2025, 14:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

IIT Guwahati converts local bamboo into high-performance automotive materials
IIT Guwahati converts local bamboo into high-performance automotive materials

News18

time2 hours ago

  • News18

IIT Guwahati converts local bamboo into high-performance automotive materials

New Delhi, Jul 24 (PTI) Researchers at the Indian Institute of Technology (IIT), Guwahati, have developed an eco-friendly composite material made of 'Bambusa tulda', a fast-growing bamboo species in northeast India, combined with biodegradable polymers, officials said on Thursday. Due to its properties, such as high strength, thermal stability, low moisture absorption and cost effectiveness, the developed composite is a suitable replacement of conventional plastics used in automotive interiors. The findings of this research have been published in the prestigious journal, Environment, Development and Sustainability (Springer Nature). Led by Poonam Kumari, Professor, Department of Mechanical Engineering, the research not only addresses the problem of plastic waste, but also provides a solution to the growing global demand for greener materials, particularly in the automotive manufacturing industry. 'The researchers tested four bamboo-based composite formulations consisting of Bambusa tulda fibres reinforced with bio-based or petroleum-based epoxies. By treating the bamboo fibres with alkali, the team improved its compatibility with the base polymer, resulting in enhanced durability for real-world use. 'The developed formulations were then evaluated on 17 different parameters to test their tensile strength, thermal resistance, impact durability, water absorption and cost per kilogram, among others," Kumari said. While these formulations had distinct strengths, none of them had all the properties to provide a balanced and high-performing option. To identify the same, the team used Multi-Criteria Decision-Making (MCDM), a structured evaluation method. 'The results observed bamboo composite made with bio-based epoxy FormuLite as the best performing option with low moisture absorption, significant thermal stability, and mechanical strength. The cost-effective nature of the composite, priced at Rs 4,300 per kilogram, makes it an eco-friendly solution for automotive parts, such as vehicle dashboards, door panels and seat backs, among others," she said. 'Developed composite can be used for designing components/parts in consumer electronics, automobiles, aerospace and sustainable building materials etc. The product will replace wood/iron/plastic components and will have similar cost and lead to fulfilment of SGD goals. This development is in line with Make in India policy under Green Tech Revolution," she added. The team is currently conducting a full life cycle assessment of the developed composite to measure its environmental impact from production to disposal. As the next step, the research team is planning to apply industrial techniques such as compression modelling and resign transfer to scale up the production. PTI GJS DIV DIV view comments First Published: July 24, 2025, 13:45 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store